Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

First Quarter 2025

First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

Thursday April 24, 2025
13:00 - 14:30 CEST (7:00am – 8:30am EDT)

Upcoming Events

24Apr

2025

First quarter 2025

First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

13:00 - 14:30 CEST (7:00am – 8:30am EDT)

Quarterly Results

Discover more

30Apr

2025

Annual General Meeting 2025

The Sanofi General Meeting will be held on April 30, 2025 at the Palais des Congrès in Paris, Porte Maillot. It will be live video webcasted.

14:30 - 16:30

Annual General Meeting (AGM)

Discover more

14May

2025

Redburn Atlantic Canada Conference

08:00 Canada

Broker Conference


Press Releases


April 15, 2025
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

April 8, 2025
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 3, 2025
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing
Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

Subscribe to investor email alerts

Sign up to receive email alerts for various types of investor content

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com